Hostname: page-component-78c5997874-ndw9j Total loading time: 0 Render date: 2024-11-17T14:08:28.074Z Has data issue: false hasContentIssue false
  • English
  • Français

An Immunologic Theory for the Development of Some Cases of Autism

Published online by Cambridge University Press:  07 November 2014

Reed P. Warren
Get access Rights & Permissions [Opens in a new window]

Abstract

Autism is a severe developmental disorder likely resulting from a combination of biologic and genetic mechanisms including an environmental stimulus. This article presents an immunologic theory for the development of some cases of autism and circumstantial biologic evidence in support of this theory. A summary of some of the latest related findings obtained in the laboratory of the author is also presented. The intent of this article is to stimulate interest in the concept that abnormalities of the immune system are involved in autistic symptoms and to provide an impetus for additional studies in this area. Such studies may provide a novel approach to the treatment of some autistic individuals.

Type
Feature Articles
Information
CNS Spectrums , Volume 3 , Issue 3: Autism: Emerging Concensus , March 1998 , pp. 71 - 79
Copyright
Copyright © Cambridge University Press 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Gillberg, C, Coleman, M. Genetic Factors. In: The Biology of the Autistic Syndromes. 2nd ed. London, England: Mac Keith Press; 1992;96–114.Google Scholar
2.Folstein, S, Rutter, M. Infantile autism: a genetic study of 21 twin pairs. J Child Psychol Psychiatry. 1977;18:297–321.Google Scholar
3.Bolton, P, Rutter, M. Genetic influences in autism. Int Rev Psychiatry. 1990;2:67–80.Google Scholar
4.Rimland, B. Infantile Autism. Englewood Cliffs, NJ: Prentice-Hall; 1964.Google Scholar
5.Chess, S, Korn, SJ, Fernandez, PB. Psychiatric Disorders of Children with Congenital Rubella. New York, NY: Brunner/Mazel; 1971.Google Scholar
6.Chess, S. Follow-up report on autism in congenital rubella. J Autism Child Schizophr. 1977;7:68–81.Google Scholar
7.Desmond, MM, Wilson, GS, Melnick, JL, et al.Congenital rubella encephalitis. J Pediatr. 1967;71:311–331.Google Scholar
8.Freedman, DA, Fox-Kolenda, BJ, Brown, SL. A multihandicapped rubella baby: the first 18 months. J Am Acad Child Adolesc Psychiatry. 1970;9:298–317.Google Scholar
9.Ornitz, EM, Guthrie, D, Farley, AH. The early development of autistic children. J Autism Child Schizophr. 1977;3:207–229.Google Scholar
10.Deykin, EY, MacMahon, G. Viral exposure and autism. Am J Epidemiol. 1979;109:628–638.Google Scholar
11.Elia, M, Bergonzi, P, Ferri, R, et al.The etiology of autism in a group of mentally retarded subjects. Brain Dysfunct. 1990;3:228–240.Google Scholar
12.Ritvo, ER, Mason-Brothers, A, Freeman, BJ, et al.The UCLA-University of Utah epidemiologic survey of autism: the etiologic role of rare diseases. Am J Psychiatry. 1990;147:1614–1621.Google Scholar
13.Starr, JG, Bart, RD, Gold, E. Inapparent congenital cytomegalovirus infection: clinical and epidemiologic characteristics in early infancy. N Engl J Med. 1970;282:1075–1078.Google Scholar
14.Stubbs, EG. Autistic symptoms in a child with congenital cytomegalovirus infection. J Autism Child Schizophr. 1978;8:37–43.Google Scholar
15.Markowitz, PI. Autism in a child with congenital cytomegalovirus infection. J Autism Dev Disord. 1983;13:249–253.Google Scholar
16.Ahlfors, K, Ivarsson, SA, Harris, S, et al.Congenital cytomegalovirus infection and disease in Sweden and the relative importance of primary and secondary infections. Scand J Infect Dis. 1984;16:129–137.Google Scholar
17.Stubbs, EG, Ash, E, Williams, CPS. Autism and congenital cytomegalovirus. J Autism Dev Disord. 1984;14:183–189.CrossRefGoogle ScholarPubMed
18.Ivarsson, SA, Bjerre, I, Vegfors, P, et al.Autism as one of several disabilities in two children with congenital cytomegalovirus infection. Neuropediatrics. 1990;21:102–103.Google Scholar
19.Rutter, M, Bartak, L. Causes of infantile autism: some considerations from recent research. J Autism Child Schizophr. 1971;1:20–32.Google Scholar
20.Knobloch, H, Pasamanick, B. Some etiologic and prognostic factors in early infantile autism and psychosis. J Pediatr. 1975;55:182–191.Google ScholarPubMed
21.Schmitt, B, Seoger, J, Kreuz, W, et al.Central nervous system involvement of children with HIV infection. Dev Med Child Neurol. 1991;33:535–540.Google Scholar
22.DeLong, GR, Bean, SC, Brown, FR. Acquired reversible autistic syndrome in acute encephalopathic illness in children. Arch Neurol. 1981;38:191–194.Google Scholar
23.Gillberg, C. Do children with autism have March birthdays? Acta Psychiatr Scand. 1990;82:152–156.Google Scholar
24.Weizman, A, Weizman, R, Szekely, GA, et al.Abnormal immune response to brain tissue antigen in the syndrome of autism. Am J Psychiatry. 1982;139:1462–1465.Google Scholar
25.Singh, VK, Warren, RP, Odell, JD, et al.Antibodies to myelin basic protein in children with autistic behavior. Brain Behav Immun. 1993;7:97–103.Google Scholar
26.Plioplys, AV, Greaves, A, Kazemi, K, et al.Immunoglobulin reactivity in autism and Rett's syndrome. Developments in Brain Dysfunction. 1994;7:12–16.Google Scholar
27.Stubbs, EG. Autistic children exhibit undetectable hemo-agglutination-inhibition antibody titers despite previous rubella vaccination. J Autism Child Schizophr. 1976;6:269–274.Google Scholar
28.Warren, RP, Margaretten, NC, Pace, NC, et al.Immune abnormalities in patients with autism. J Autism Dev Disord. 1986;16:189–197.Google Scholar
29.Stubbs, EG, Crawford, ML, Burger, DR, et al.Depressed lymphocyte responsiveness in autistic children. J Autism Child Schizophr. 1977;7:49–55.Google Scholar
30.Warren, RP, Yonk, LJ, Burger, RA, et al.Deficiency of suppressor-inducer (CD4+CD45R+) T cells in autism. Immunol Invest. 1990;19:245–252.Google Scholar
31.Yonk, LJ, Warren, RP, Burger, RA, et al.CD4+ helper T cell depression in autism. Immunol Lett. 1990;25:341–346.Google Scholar
32.Wright, HH, Abramson, RK, Self, S, et al. Serotonin may alter lymphocyte cells surface markers in autistic probands. Presented at the Annual Meeting of the American Academy of Child and Adolescent Psychiatry; October 25, 1990; Chicago, Ill. Scientific Proceedings. NR abstract 12.Google Scholar
33.Denney, DR, Frei, BW, Gaffney, GR. Lymphocyte subsets and interleukin-2 receptors in autistic children. J Autism Dev Disord. 1996;26:87–97.Google Scholar
34.Tsaltas, MO. A pilot study on allergic responses. J Autism Dev Disord. 1986;16:91–92.Google Scholar
35.Warren, RP, Foster, A, Margaretten, NC. Reduced natural killer cell activity in autism. J Am Acad Child Adolesc Psychiatry. 1987;26:333–335.Google Scholar
36.Plioplys, AV, Greaves, A, Kazemi, K, et al.Lymphocyte function in autism and Rett Syndrome. Neuropsychobiology. 1994;7:12–16.Google Scholar
37.Warren, RP, Yonk, J, Burger, RW, et al.DR positive T cells in autism: association with decreased plasma levels of the complement C4B protein. Neuropsychobiology. 1995;31:53–57.Google Scholar
38.Ammann, AJ. Antibody (B cell) immunodeficiency disorders. In: Appleton, Lang, eds. Basic and Clinical Immunology. 7th ed. Norwalk, Conn: Prentice Hall; 1991;322–334.Google Scholar
39.Warren, RP, Odell, JD, Warren, WL, et al.Brief report: immunoglobulin a deficiency in a subset of autistic subjects. J Autism Dev Disord. 1997;27:187–192.Google Scholar
40.Warren, RP, Singh, VK, Cole, P, et al.Increased frequency of the null allele at the complement C4B locus in autism. Clin Exp Immunol. 1991;83:438–440.Google Scholar
41.Warren, RP, Singh, VK, Cole, P, et al.Possible association of the extended MHC haplotype B44-SC30-DR4 with autism. Immunogenetics. 1992;36:203–207.Google Scholar
42.Daniels, WW, Warren, RP, Odell, JD, et al.Increased frequency of the extended or ancestral haplotype B44-SC30-DR4 in autism. Neuropsychobiology. 1995;32:120–123.Google Scholar
43.Alper, CA, Awdeh, ZL, Yunis, EJ. Complotypes and extended haplotypes in laboratory medicine: complement in laboratory medicine. Complement Inflammation. 1989;6:8–18.Google Scholar
44.Degli-Esposti, M, Leaver, AL, Christiansen, FT, et al.Ancestral haplotypes: conserved population MHC haplotypes. Hum Immunol. 1992;34:242–252.Google Scholar
45.Fraser, PA, Stern, S, Larson, MG, et al.HLA extended haplotypes in childhood and adult onset HLA-DR4-associated arthropathies. Tissue Antigens. 1990;35:56–59.Google Scholar
46.Gregersen, PK, Silver, J, Winchester, RJ. The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987;30:1205–1213.Google Scholar
47.Roudier, J, Petersen, J, Rodhes, G, et al.Susceptibility to rheumatoid arthritis maps to a T cell epitope shared by the HLA-Dw4 DR, B1 chain and the Epstein-Barr virus glycoprotein gp110. Proc Natl Acad Sci USA. 1989;86:5104–5108.Google Scholar
48.Albani, S, Tuckwell, J, Esparza, L, et al.The susceptibility sequence to rheumatoid arthritis is a cross reactive B epitope shared by E. coli heat shock protein and the HLA DRBl*0401 molecule. J Clin Invest. 1992;89:327–331.Google Scholar
49.Salvat, S, Auger, I, Rochelle, L, et al.Tolerance to a self-peptide from the third hypervariable region of HLA DRB1*0401 in rheumatoid arthritis patients and normal subjects. J Immunol. 1994;153:5321–5329.Google Scholar
50.Warren, RP, Odell, JD, Warren, WL, et al.Strong association of the third hypervariable region of HLA-DR 1 with autism. J Neuroimmunol. 1996;67:97–102.Google Scholar